Giant Cell Arteritis: all 173 studies
Page 2 of 2. Open to participants first (49), then studies with results posted, then the rest; newest registration first within each.
- The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT04239521
- Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCAStatus unknownNCT04239196Phase 2
- Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease CourseCompletedNCT04204876
- Comparison of 22Mhz and 18Mhz High-frequency Probes for the Ultrasound Study of Temporal Arteries in Patients Suspected of Having Giant Cell ArteritisCompletedNCT04204512
- Collection and Analysis of the Clinical and Biological Characteristics of Patients Treated for Giant Cells ARTEitis (Horton's Disease)CompletedNCT04142515
- PET Imaging of Giant Cell and Takayasu ArteritisActive, not recruitingNCT04071691
- Low-dose Interleukin-2 Treatment on Polymyalgia RheumaticaStatus unknownNCT04062006Phase 2
- TARGET GCAT RegistryTerminatedNCT04049071
- BAriCitinib Healing Effect in earLy pOlymyalgia RheumaticaCompletedNCT04027101Phase 2
- Chewing Gum Test for the Diagnosis of Giant Cell Arteritis (Horton's Disease) - ChewingHortCompletedNCT04010097Not applicable
- Pilot Study of the Impact of Giant Cell Arteritis and Its Treatment on the Autonomy of the Elderly in the First Year of CareTerminatedNCT03961113
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled TrialActive, not recruitingNCT03892785Phase 3
- Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBOCompletedNCT03841734Phase 3
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)CompletedNCT03812302Phase 2
- Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell ArteritisCompletedNCT03765424
- Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and TocilizumabCompletedNCT03745586Phase 1/2
- Ustekinumab for the Treatment of Relapse of Refractory Giant Cell ArteritisCompletedNCT03711448Phase 2
- Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseTerminatedNCT03656627Phase 1
- Treatment With Leflunomide in Patients With Polymyalgia RheumaticaStatus unknownNCT03576794Phase 3
- Low Dose Naltrexone to Improve Physical Health in Patients With VasculitisCompletedNCT03482479Phase 2
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT03410290
- Diagnostic Accuracy of FDG PET/CT of Cranial Arteries in GCACompletedNCT03409913
- Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-DopplerCompletedNCT03360162
- Study of T Lymphocytes in Patients With Horton DiseaseStatus unknownNCT03313102Not applicable
- FDG Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid TreatmentCompletedNCT03285945
- A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)CompletedNCT03263715Phase 3
- Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.Status unknownNCT03244709Phase 4
- An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)CompletedNCT03202368Phase 3
- A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)WithdrawnNCT03192969Phase 3
- Polymyalgia Rheumatica and Giant Cell ArteritisStatus unknownNCT02985424
- Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORECompletedNCT02908217Phase 3
- Giant Cell Arteritis and Anakinra TrialTerminatedNCT02902731Phase 3
- Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia RheumaticaWithdrawnNCT02899026Phase 3
- Lymphocyte and Cytokine Disturbances in Polymyalgia RheumaticaCompletedNCT02888496
- Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's DiseaseCompletedNCT02857192Not applicable
- Biomarkers in Giant Cells ArteritisTerminatedNCT02844023Not applicable
- Giant Cell Arteritis and PET Scan (GAPS) StudyCompletedNCT02771483
- Delayed Release Prednisone in PMRTerminatedNCT02702778Phase 2
- Aetiology of TemporaL Arteritis StudyWithdrawnNCT02584517
- Giant Cell Arteritis: Improving Use of Ultrasound EvaluationStatus unknownNCT02523625
- Impact of Vasculitis on Employment and IncomeCompletedNCT02476292
- Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton DiseaseTerminatedNCT02473029
- Study of Circulating Microparticles in Giant Cell ArteritisStatus unknownNCT02333708
- VCRC Patient Contact Registry Patient-Reported Data Validation StudyCompletedNCT02190942
- Educational Needs of Patients With Systemic VasculitisCompletedNCT02190929
- Vasculitis Illness Perception (VIP) StudyCompletedNCT02190916
- Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
- Study of the T CD8 Immune Response in Horton's DiseaseCompletedNCT02158208
- Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)CompletedNCT02065297
- Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.CompletedNCT01910038Phase 2
- A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMRTerminatedNCT01821040Phase 3
- Carotid Artery Neovascularization in Takayasu's and Giant Cell ArteritisCompletedNCT01795456
- Tocilizumab Effect iN pOlymyalgia RheumaticaCompletedNCT01713842Phase 2
- Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell ArteritisCompletedNCT01588483
- Infliximab Therapy in Patients With Refractory Polymyalgia RheumaticaStatus unknownNCT01423591Phase 3
- Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell ArteritisStatus unknownNCT01400464Phase 4
- Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica PatientsCompletedNCT01169597Phase 4
- Diagnostic Study of Temporal ArteritisStatus unknownNCT01130857
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT01066208
- Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)CompletedNCT00974883
- Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia RheumaticaCompletedNCT00847236
- Etanercept Treatment in the Early Course of Polymyalgia RheumaticaCompletedNCT00524381Phase 3
- Hydroxychloroquine in Giant Cell ArteritisCompletedNCT00430807Phase 3
- Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal ArteritisStatus unknownNCT00361192Early Phase 1
- Determining Disease Activity Biomarkers in Individuals With Giant Cell ArteritisCompletedNCT00315497
- HECTHOR: Humira to Spare Steroids in Giant Cell ArteritisCompletedNCT00305539Phase 3
- MRI Superficial Temporal ArteryCompletedNCT00188448Phase 1
- Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.CompletedNCT00138983Phase 3
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell ArteritisTerminatedNCT00076726Phase 2
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable
- Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell ArteritisCompletedNCT00004686Phase 2